Is your doctor using AI?

• The TGA says 8 out of 12 medical scribe products being used by doctors in Australia may be affecting diagnostic and clinical decisions. These products must now go through the registration process as medical devices.

• Despite data showing younger people are drinking less, rates of hospitalisation for alcohol related liver diseases in that cohort are still higher than they were before the pandemic.

• A comparison of twenty-one different anti-depressant medications showed they were more effective than placebo in adults with major depressive disorder. But some medications were found to be slightly more beneficial than others. How does that affect prescribing?

References

• TGA - Digital Scribe review outcomes
• Alcohol-related liver disease epidemiology in Victoria
• ABC News: Severe alcohol-related liver disease common in younger Australians
• Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis - The Lancet
• FDA Requires Safety Labeling Changes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) Due to Potential Increased Risk of Rare But Serious Eye Condition
• TGA Medicine Safety Update: GLP-1 RAs and rare vision disorder
• Health Report: Heart disease prevention drug fails at final hurdle
• Interleukin-6 Inhibition with Ziltivekimab for Atherosclerotic Disease
• Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a)
• Calvary Health Care purchase of Newcastle Private Hospital and Hunter Valley Private Hospital